Predicting immunotherapy response with spatial data

Recent studies demonstrate that spatial proximity metrics of immune and tumor cells significantly outperform traditional PD-L1 expression testing in predicting immunotherapy response across multiple cancer types, suggesting multi-marker spatial models provide improved predictive power for clinical use.

This Wire brief sits within Fusion42's coverage of Drug Discovery.